Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


'Escobar' Conundrum: 2017's Biggest Story In Medtech False-Claims Enforcement

Executive Summary

A Supreme Court decision that established a new standard in False Claims Act cases was key to FCA enforcement in 2017, when FCA enforcement remained a priority under the Trump administration.


Related Content

Mid-Year Enforcement Roundup: Focus On Opioids, As Other Areas Lag
US DoJ Memos May Hint At Enforcement Stepdown
FCA Liability After Escobar: Challenges And Opportunities For Device Companies





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts